Beta Bionics, Inc.
BBNX· Nasdaq
BBNXBeta Bionics, Inc.
Quarterly figures for Beta Bionics, Inc., with source filings when available.
10 quarters. Mar 31, 2024 to Jun 30, 2026. USD.
Beta Bionics, Inc. has filed its 10-Q within 21 to 36 days of period end across its last 5 quarters. The 10-K runs 55 to 84 days.
Beta Bionics, Inc. · CIK 1674632 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Jul 29, 2026 · after-hours | Jul 29, 2026 | 29 d | 10-Q | $32.01M | +37.8% | -$0.53 | |
| Q1 2026 | Mar 31, 2026 | Apr 21, 2026 · after-hours | Apr 21, 2026 | 21 d | 10-Q | ||||
| FY 2025 | |||||||||
| Q4 2025derived | Dec 31, 2025 | Feb 17, 2026 · after-hours | Feb 24, 2026 | 55 d | 10-K | $32.12M | +57.1% | — | |
| Q3 2025 | Sep 30, 2025 | Oct 28, 2025 · after-hours | Oct 28, 2025 | ||||||
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | Mar 25, 2025 · after-hours | Mar 25, 2025 | 84 d | 10-K | $20.44M | — | — | |
| Q3 2024 | Sep 30, 2024 | — | — | ||||||
| $27.63M |
| +56.6% |
| -$0.49 |
| 28 d |
| 10-Q |
| $27.25M |
| +63.1% |
| -$0.33 |
| Q2 2025 | Jun 30, 2025 | Jul 29, 2025 · after-hours | Jul 29, 2025 | 29 d | 10-Q | $23.24M | +54.4% | -$0.39 |
|---|
| Q1 2025 | Mar 31, 2025 | May 6, 2025 · after-hours | May 6, 2025 | 36 d | 10-Q | $17.64M | +36.4% | -$0.93 |
|---|
| — |
| — |
| $16.71M |
| — |
| -$1.46 |
| Q2 2024 | Jun 30, 2024 | — | — | — | — | $15.05M | — | -$2.37 |
|---|
| Q1 2024 | Mar 31, 2024 | — | — | — | — | $12.93M | — | -$2.07 |
|---|
